Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 11 symbols : LLY save search
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-11 (Crawled : 13:07) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.4%
H: 0.14%
C: -1.03%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -1.07%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.12%
H: 0.46%
C: -0.24%
SUPN | $29.43 1.94% 1.9% 360K
|
Health Technology
|
| O: 0.12%
H: 3.37%
C: 3.33%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
OTIC | $0.077
|
Health Technology
|
| O: 1.81%
H: 2.48%
C: 1.42%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 2.46%
H: 1.25%
C: 0.36%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.63%
H: 0.83%
C: -0.66%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.28%
H: 1.23%
C: -0.35%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 1.62%
H: 0.65%
C: -6.07%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.3%
H: 1.43%
C: 0.22%
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: 1.28%
H: 6.55%
C: 6.55%
covid phase 2 trial enroll
Dicerna to Host Webinar on DCR-AUD Alcohol Use Disorder Candidate on March 18, 2021
Published: 2021-03-11 (Crawled : 13:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.24%
H: 0.38%
C: -0.04%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 2.62%
H: 3.97%
C: 3.45%
alcohol use disorder
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
Published: 2021-03-11 (Crawled : 02:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.67%
H: 0.96%
C: 0.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 44.57%
H: 0.75%
C: -8.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
covid treatment risk biotech iot
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.